Condition
Ductal Carcinoma in Situ of the Breast
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Active Not Recruiting1
Not Yet Recruiting1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT00165256Phase 2Active Not RecruitingPrimary
Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
NCT07245316Not ApplicableNot Yet RecruitingPrimary
Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial
NCT03109522Not ApplicableUnknown
Axillary Reverse Mapping (ARM) Technique
Showing all 3 trials